Review



ace2 over expressing a549 cells  (InvivoGen)


Bioz Verified Symbol InvivoGen is a verified supplier
Bioz Manufacturer Symbol InvivoGen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    InvivoGen ace2 over expressing a549 cells
    Comparative fitness of EG.5.1 and XBB.1.9.1 (A) Beta-galactosidase staining on differentiated nasal organoid monolayers from a younger adult (28 years old) and an older adult (68 years old). Upper panel: light microscopy; Lower panel: Nuclei were counterstained with DAPI (blue). Scale bar, 100 μm (left), 50 μm (right). (B) Viral replication in <t>VeroE6/TMPRSS2</t> cell line, <t>A549/TMPRSS2/ACE2</t> cell line or nasal organoids derived from the younger adult or the older adult. The viral load was determined using RT-qPCR. Data represent mean, and error bar represents one standard deviation. The viral load at each time point was compared using Student’s t test. ∗, p < 0.05. (C) Competition assay between EG.5.1 and XBB.1.9.1. Human nasal organoid derived from the young adult was infected with EG.5.1 and XBB.1.9.1 at a EG.5.1:XBB.1.9.1 TCID 50 ratio of 1:1. Next generation sequencing was performed on the cell culture supernatants that were collected at 24, 48 and 72 hpi. The percentage of reads corresponding to the EG.5.1 was determined using the spike amino acid residues 52 and 456. The data at 0 h time point represents the sequencing result of the 1:1 mixture. Data represent mean, and error bar represents one standard deviation.
    Ace2 Over Expressing A549 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 194 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ace2 over expressing a549 cells/product/InvivoGen
    Average 96 stars, based on 194 article reviews
    ace2 over expressing a549 cells - by Bioz Stars, 2026-03
    96/100 stars

    Images

    1) Product Images from "Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid"

    Article Title: Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid

    Journal: iScience

    doi: 10.1016/j.isci.2024.109706

    Comparative fitness of EG.5.1 and XBB.1.9.1 (A) Beta-galactosidase staining on differentiated nasal organoid monolayers from a younger adult (28 years old) and an older adult (68 years old). Upper panel: light microscopy; Lower panel: Nuclei were counterstained with DAPI (blue). Scale bar, 100 μm (left), 50 μm (right). (B) Viral replication in VeroE6/TMPRSS2 cell line, A549/TMPRSS2/ACE2 cell line or nasal organoids derived from the younger adult or the older adult. The viral load was determined using RT-qPCR. Data represent mean, and error bar represents one standard deviation. The viral load at each time point was compared using Student’s t test. ∗, p < 0.05. (C) Competition assay between EG.5.1 and XBB.1.9.1. Human nasal organoid derived from the young adult was infected with EG.5.1 and XBB.1.9.1 at a EG.5.1:XBB.1.9.1 TCID 50 ratio of 1:1. Next generation sequencing was performed on the cell culture supernatants that were collected at 24, 48 and 72 hpi. The percentage of reads corresponding to the EG.5.1 was determined using the spike amino acid residues 52 and 456. The data at 0 h time point represents the sequencing result of the 1:1 mixture. Data represent mean, and error bar represents one standard deviation.
    Figure Legend Snippet: Comparative fitness of EG.5.1 and XBB.1.9.1 (A) Beta-galactosidase staining on differentiated nasal organoid monolayers from a younger adult (28 years old) and an older adult (68 years old). Upper panel: light microscopy; Lower panel: Nuclei were counterstained with DAPI (blue). Scale bar, 100 μm (left), 50 μm (right). (B) Viral replication in VeroE6/TMPRSS2 cell line, A549/TMPRSS2/ACE2 cell line or nasal organoids derived from the younger adult or the older adult. The viral load was determined using RT-qPCR. Data represent mean, and error bar represents one standard deviation. The viral load at each time point was compared using Student’s t test. ∗, p < 0.05. (C) Competition assay between EG.5.1 and XBB.1.9.1. Human nasal organoid derived from the young adult was infected with EG.5.1 and XBB.1.9.1 at a EG.5.1:XBB.1.9.1 TCID 50 ratio of 1:1. Next generation sequencing was performed on the cell culture supernatants that were collected at 24, 48 and 72 hpi. The percentage of reads corresponding to the EG.5.1 was determined using the spike amino acid residues 52 and 456. The data at 0 h time point represents the sequencing result of the 1:1 mixture. Data represent mean, and error bar represents one standard deviation.

    Techniques Used: Staining, Light Microscopy, Derivative Assay, Quantitative RT-PCR, Standard Deviation, Competitive Binding Assay, Infection, Next-Generation Sequencing, Cell Culture, Sequencing


    Figure Legend Snippet:

    Techniques Used: Virus, Recombinant, Modification, Saline, Plasmid Preparation, Staining, Sequencing, Software



    Similar Products

    96
    InvivoGen ace2 over expressing a549 cells
    Comparative fitness of EG.5.1 and XBB.1.9.1 (A) Beta-galactosidase staining on differentiated nasal organoid monolayers from a younger adult (28 years old) and an older adult (68 years old). Upper panel: light microscopy; Lower panel: Nuclei were counterstained with DAPI (blue). Scale bar, 100 μm (left), 50 μm (right). (B) Viral replication in <t>VeroE6/TMPRSS2</t> cell line, <t>A549/TMPRSS2/ACE2</t> cell line or nasal organoids derived from the younger adult or the older adult. The viral load was determined using RT-qPCR. Data represent mean, and error bar represents one standard deviation. The viral load at each time point was compared using Student’s t test. ∗, p < 0.05. (C) Competition assay between EG.5.1 and XBB.1.9.1. Human nasal organoid derived from the young adult was infected with EG.5.1 and XBB.1.9.1 at a EG.5.1:XBB.1.9.1 TCID 50 ratio of 1:1. Next generation sequencing was performed on the cell culture supernatants that were collected at 24, 48 and 72 hpi. The percentage of reads corresponding to the EG.5.1 was determined using the spike amino acid residues 52 and 456. The data at 0 h time point represents the sequencing result of the 1:1 mixture. Data represent mean, and error bar represents one standard deviation.
    Ace2 Over Expressing A549 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ace2 over expressing a549 cells/product/InvivoGen
    Average 96 stars, based on 1 article reviews
    ace2 over expressing a549 cells - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    Comparative fitness of EG.5.1 and XBB.1.9.1 (A) Beta-galactosidase staining on differentiated nasal organoid monolayers from a younger adult (28 years old) and an older adult (68 years old). Upper panel: light microscopy; Lower panel: Nuclei were counterstained with DAPI (blue). Scale bar, 100 μm (left), 50 μm (right). (B) Viral replication in VeroE6/TMPRSS2 cell line, A549/TMPRSS2/ACE2 cell line or nasal organoids derived from the younger adult or the older adult. The viral load was determined using RT-qPCR. Data represent mean, and error bar represents one standard deviation. The viral load at each time point was compared using Student’s t test. ∗, p < 0.05. (C) Competition assay between EG.5.1 and XBB.1.9.1. Human nasal organoid derived from the young adult was infected with EG.5.1 and XBB.1.9.1 at a EG.5.1:XBB.1.9.1 TCID 50 ratio of 1:1. Next generation sequencing was performed on the cell culture supernatants that were collected at 24, 48 and 72 hpi. The percentage of reads corresponding to the EG.5.1 was determined using the spike amino acid residues 52 and 456. The data at 0 h time point represents the sequencing result of the 1:1 mixture. Data represent mean, and error bar represents one standard deviation.

    Journal: iScience

    Article Title: Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid

    doi: 10.1016/j.isci.2024.109706

    Figure Lengend Snippet: Comparative fitness of EG.5.1 and XBB.1.9.1 (A) Beta-galactosidase staining on differentiated nasal organoid monolayers from a younger adult (28 years old) and an older adult (68 years old). Upper panel: light microscopy; Lower panel: Nuclei were counterstained with DAPI (blue). Scale bar, 100 μm (left), 50 μm (right). (B) Viral replication in VeroE6/TMPRSS2 cell line, A549/TMPRSS2/ACE2 cell line or nasal organoids derived from the younger adult or the older adult. The viral load was determined using RT-qPCR. Data represent mean, and error bar represents one standard deviation. The viral load at each time point was compared using Student’s t test. ∗, p < 0.05. (C) Competition assay between EG.5.1 and XBB.1.9.1. Human nasal organoid derived from the young adult was infected with EG.5.1 and XBB.1.9.1 at a EG.5.1:XBB.1.9.1 TCID 50 ratio of 1:1. Next generation sequencing was performed on the cell culture supernatants that were collected at 24, 48 and 72 hpi. The percentage of reads corresponding to the EG.5.1 was determined using the spike amino acid residues 52 and 456. The data at 0 h time point represents the sequencing result of the 1:1 mixture. Data represent mean, and error bar represents one standard deviation.

    Article Snippet: TMPRSS2 and ACE2 over-expressing A549 cells (A549/TMPRSS2/ACE2) were obtained from InvivoGen (Catalog code: a549-hace2tpsa).

    Techniques: Staining, Light Microscopy, Derivative Assay, Quantitative RT-PCR, Standard Deviation, Competitive Binding Assay, Infection, Next-Generation Sequencing, Cell Culture, Sequencing

    Journal: iScience

    Article Title: Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid

    doi: 10.1016/j.isci.2024.109706

    Figure Lengend Snippet:

    Article Snippet: TMPRSS2 and ACE2 over-expressing A549 cells (A549/TMPRSS2/ACE2) were obtained from InvivoGen (Catalog code: a549-hace2tpsa).

    Techniques: Virus, Recombinant, Modification, Saline, Plasmid Preparation, Staining, Sequencing, Software